US Patent 9724402 None
Patent 9724402 was granted and assigned to Pfizer Limited on August, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 7 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+425 characters)
Article
Patent abstract
In one aspect, the invention relates to an isolated polypeptide comprising an amino acid sequence that is at least 95% identical to SEQ ID NO: 71 in another aspect, the invention relates to an immunogenic composition including an isolated non-lipidated, non-pyruvylated ORF2086 polypeptide from Neisseria meningitidis serogroup B, and at least one conjugated capsular saccharide from a meningococcal serogroup.
Edits on 30 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Annaliesa Sybil Anderson0
Justin Keith Moran0
Kathrin Ute Jansen0
Mark E. Ruppen0
Susan Kay Hoiseth0
Edits on 21 Jun, 2023
Golden AI
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09724402 None US Patent 9724402 None
Infobox
Patent Number
097244020
Patent Number
97244020
Edits on 22 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
097244020
Date of Patent
August 8, 2017
0Patent Application Number
152370050
Date Filed
August 15, 2016
0Patent Primary Examiner
Edits on 14 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09724402 None
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09724402
Date of patent
August 8, 2017
Patent application number
15237005
Date Filed
August 15, 2016
Patent primary examiner
Find more entities like US Patent 9724402 None
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.